Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 27, 2013
Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infectionsYusuke Tanigawara, Mitsuo Kaku, Kyoichi Totsuka, et al.
Biological & Pharmaceutical Bulletin|August 2, 2006
Linear pharmacokinetics of micafungin and its active metabolites in Japanese pediatric patients with fungal infectionsKenji Tabata, Masataka Katashima, Akio Kawamura, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Population pharmacokinetics of an angiotensin II receptor antagonist, telmisartan, in healthy volunteers and hypertensive patientsShinji Tatami, Akiko Sarashina, Norio Yamamura, et al.
Drug Metabolism and Pharmacokinetics|September 2, 2006
Population pharmacokinetic analysis of micafungin in Japanese patients with fungal infectionsKenji Tabata, Masataka Katashima, Akio Kawamura, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2006
Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureusReiko Sato, Yusuke Tanigawara, Mitsuo Kaku, et al.
Drug Metabolism and Pharmacokinetics|October 23, 2004
Relationship between pharmacokinetic parameters and occurrence of adverse events in clinical trials performed in Europe and United States for an angiotensin II receptor antagonist, telmisartanShinji Tatami, Akiko Sarashina, Norio Yamamura, et al.
International Journal of Antimicrobial Agents|July 7, 2019
Cerebrospinal pharmacokinetic and pharmacodynamic analysis of efficacy of meropenem in paediatric patients with bacterial meningitisYuka Ohata, Yoshiko Tomita, Keisuke Sunakawa, et al.
Therapeutic Drug Monitoring|September 23, 2022
Pharmacodynamic Model-Based Safety Management of Eribulin-Induced Myelosuppression in Patients With Breast CancerHidefumi Kasai, Kim Linda Poppenberg, Valentina Fermanelli, et al.
Metabolomics : Official Journal of the Metabolomic Society|August 8, 2017
Effect of everolimus on the glucose metabolic pathway in mouse skeletal muscle cells (C2C12)Kayoko Yoshida, Chiyo K Imamura, Kanako Hara, et al.
Drug Metabolism and Pharmacokinetics|July 13, 2011
Optimal dosage regimen of meropenem for pediatric patients based on pharmacokinetic/pharmacodynamic considerationsYuka Ohata, Yoshiko Tomita, Mitsunobu Nakayama, et al.
Pageof 10